Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

NCT02177357 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Pramipexole
DRUG: Placebo

Sponsor

Boehringer Ingelheim